Cannabis Studies & Research


Medical cannabis in schools: The experiences of caregivers and clinicians

Are you a caregiver of a child taking medical cannabis, or a clinician who authorizes medical cannabis for children?

The University of Saskatchewan and the Canadian Childhood Cannabinoid Clinical Trials are conducting a study to learn more about the experiences of parents and caregivers of children who take medical cannabis and clinicians who authorize medical cannabis for children, regarding medical cannabis in schools. Participation will involve a one on one interview with a researcher.

If you are interested in taking part in an interview, please click here.

Establishing Research Priorities: An Exploration of First Nations, Inuit and Métis Women and Gender-Diverse People’s Needs in Cannabis and Mental Health

The Native Women’s Association of Canada is looking for participants for a study on Aug 16th & 19th about the impacts of cannabis on Inuit women living with mental health issues.

Participants must be:

  • 18 years of age or older
  • Women or gender-diverse
  • Inuit
  • Available for a 3-hour session

To participate in the session on August 16th, click here.

To participate in the session on August 19th, click here.

BC Cancer Clinical Trial: Cannabis for Cancer-Related Symptoms

This new study will research if cannabis oils are effective in treating symptoms (pain, nausea, sleep disturbance and anxiety) related to your cancer or cancer treatment.

To qualify for participation:

  1. You are at least 19 years old
  2. Your symptom(s) are expected to be stable throughout the duration of the study
  3. You are willing to commit to not taking cannabis in any form other than the study products for the duration of the study
  4. You are accessible by telephone
  5. Your symptoms are related to your cancer or cancer-treatment
  6. You are willing to not drink any alcohol for the duration of the study
  7. You are willing to commit to not operating a vehicle or heavy machinery for the duration of the study

If you are interested in participating, or for more information please click here.

Cannabis Use for HIV Symptom Management Survey

The broad objective of this study is to understand the experience of people living with HIV who use cannabis to help reduce and manage their symptoms.

The study is funded by the Canadian Institutes of Health Research (CIHR) and the Principal Investigator is Dr. Marilou Gagnon of the University of Victoria. Members of the research team include Dr. Adrian Guta, Dr. Zach Walsh, Dr. Carol Strike, Dr. Jason Nickerson, Nancy Chow, Richard Elliott, and Trevor Stratton.

To participate in this study, participants must:

  1. Identify as an adult living with HIV in Canada
  2. Use cannabis to reduce and manage symptoms (for example, appetite loss, weight loss (wasting), nausea, vomiting, pain, anxiety, depression, stress, insomnia, etc.)
  3. Be able to complete the online survey in English or French


Alzheimer’s Disease

Emerging Promise of Cannabinoids for the Management of Pain and Associated Neuropathological Alterations in Alzheimer’s Disease Frontiers in Pharmacology (2020)

Attitudes, beliefs, and changing trends of cannabidiol (CBD) oil use among caregivers of individuals with Alzheimer’s disease Complementary Therapies in Medicine (2021)

Autism Spectrum Disorder

Medical Cannabis in the Treatment of Patients with Autism Spectrum Disorder American Academy of Neurology (2018)


Cannabinoids for Cancer Treatment: Progress and Promise American Association for Cancer (2008)

The Efficacy of Medical Marijuana in the Treatment of Cancer-Related Pain Journal of Palliative Medicine (2020)

Anti-Cancer Potential of Cannabinoids, Terpenes, and Flavonoids Present in Cannabis MDPI (2020)

Oral THC:CBD cannabis extract for refractory chemotherapy-induced nausea and vomiting (CINV): a randomized, placebo-controlled, phase 2 crossover trial Annals of Oncology (2020)

Understanding cancer survivors’ reasons to medicate with cannabis: A qualitative study based on the theory of planned behaviour Wiley Online Library: Cancer Medicine (2020)

A randomized trial of medical cannabis in patients with stage IV cancers to assess feasibility, dose requirements, impact on pain and opioid use, safety, and overall patient satisfaction Support Care Cancer (2021)

Breast Cancer

Antitumor Activity of Abnormal Cannabidiol and Its Analog O-1602 in Taxol-Resistant Preclinical Models of Breast Cancer Frontiers in Pharmacology (2019)

Brain Cancer

Concomitant Treatment of Malignant Brain Tumors with CBD – A Case Series and Review of Literature. Anticancer Research (2019)

A phase II double-blind, randomized clinical trial assessing the tolerability of two different ratios of cannabis in patients with glioblastoma multiforme (GMB). Journal of Clinical Oncology (2020)

Daily Lifestyle Modifications to Improve Quality of Life and Survival in Glioblastoma: A Review MDPI (2021)

A Retrospective Cohort Study of Medical Cannabis Treatment in Patients with Glioblastoma Multiforme Neurology (2021)

Cervical Cancer

Cannabidiol rather than Cannabis sativa extracts inhibit cell growth and induce apoptosis in cervical cancer cells BMC Complementary and Alternative Medicine (2016)

Colon Cancer

Activation of Cannabinoid Receptor 2 Prevents Colitis-Associated Colon Cancer through Myeloid Cell D-activation Upstream of IL-22 Production iScience (2020)

Lung Cancer

Striking lung cancer response to self-administration of cannabidiol: A case report and literature review Sage Open Medical Case Reports (2019)

Pancreatic Cancer

Anticancer Effect of New Cannabinoids Derived from Tetrahydrocannabinolic Acid on PANC-1 and AsPC-1 Human Pancreas Tumor Cells Journal of Pancreatic Cancer (2020)

Prostate Cancer

Proapoptotic effect of endocannabinoid in prostate cancer cells Oncology Reports (2015)


Cannabis is associated with blood pressure reduction in older adults – A 24-hours ambulatory blood pressure monitoring study European Journal of Internal Medicine (2021)


Cannabinoids for the Neuropsychiatric Symptoms of Dementia: A Systematic Review and Meta-Analysis The Canadian Journal of Psychiatry (2019)

Cannabinoids in the management of frontotemporal dementia: a case series Future Medicine (2020)


Cannabidiol Protects Against High Glucose-Induced Oxidative Stress and Cytotoxicity in Cardiac Voltage-Gated Sodium Channels The British Pharmacological Society (2020)

Cannabis use prevalence among individuals with diabetes: The National Survey on Drug Use and Health, 2005-2018 Drug and Alcohol Dependence (2020)


Cannabis Use, a Self Management Strategy Among Australian Women With Endometriosis: Results From a National Online Survey Journal of Obstetrics and Gynaecology Canada (2019)


Cannabis in the Treatment of Pediatric Epilepsy Bonni Goldstein, MD (2015)

CBD Enriched Medical Cannabis for Intractable Pediatric Epilepsy European Journal of Epilepsy (2016)

An Australian nationwide survey on medicinal cannabis use for epilepsy: History of antiepileptic drug treatment predicts medicinal cannabis use Epilepsy & Behavior (2017)

First Canadian paediatric study of mixed THC/CBD cannabis oil shows promise for children with drug-resistant epilepsy SickKids (2018)

Position Statement on the Use of Medical Cannabis for the Treatment of Epilepsy in Canada Canadian League Against Epilepsy Medical Therapeutics Committee (2019)

Cannabinoids in the Treatment of Epilepsy: Current Status and Future Prospects Neuropsychiatric Disease and Treatment (2020)

Slow Titration of Cannabidiol Add-On in Drug-Resistant Epilepsies Can Improve Safety With Maintained Efficacy in an Open-Label Study Frontiers in Pharmacology (2020)

An Open Retrospective Study of a Standardized Cannabidiol Based-Oil in Treatment-Resistant Epilepsy Cannabis and Cannabinoid Research (2020)

The long-term efficacy of cannabidiol in the treatment of refractory epilepsy International League Against Epilepsy (2021)

Time to onset of cannabidiol treatment effects in Dravet syndrome: Analysis from two randomized controlled trials Epilepsia (2021)

Effect of Cannabidiol on Interictal Epileptiform Activity and Sleep Architecture in Children with Intractable Epilepsy: A Prospective Open-Label Study CNS Drugs (2021)


Medical Cannabis for the Treatment of Fibromyalgia Journal of Clinical Rheumatology (2018)

Adding Medical Cannabis to Standard Analgesic Treatment for Fibromyalgia: A Prospective Observational Study Clinical and Experimental Rheumatology (2020)

Ingestion of a THC-Rich Cannabis Oil in People with Fibromyalgia: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial Pain & Substance Use Disorders (2020)

Survey: Fibromyalgia Patients Frequently Report Using Medical Cannabis Norml (2021)

Substituting Cannabidiol for Opioids and Pain Medications Among Individuals With Fibromyalgia: A Large Online Survey U.S. Association for the Study of Pain (2021)


Cannabinoid use in patients with gastroparesis and related disorders: prevalence and benefit The American Journal of Gastroenterology (2019)

Impact of Cannabinoids on Symptoms of Refractory Gastroparesis: A Single-center Experience Cureus (2019)


Cannabis Consumption in People Living with HIV: Reasons for Use, Secondary Effects, and Opportunities for Health Education Cannabis and Cannabinoid Research (2019)

Inflammatory Bowel Disease

Insights into the role of cannabis in the management of inflammatory bowel disease Therapeutic Advances in Gastroenterology (2019)

Medical cannabis for inflammatory bowel disease: real-life experience of mode of consumption and assessment of side-effects  European Journal of Gastroenterology & Hepatology (2019)

Cannabis for the treatment of Inflammatory Bowel Disease: a true medicine or a false promise? Rambam Maimonides Medical Journal (2020)

Association Between Cannabis Use and Healthcare Utilization in Patients with Irritable Bowel Syndrome: A Retrospective Cohort Study Cureus (2020)

Inflammatory Bowel Disease and Cannabis: A Practical Approach for Clinicians Advances in Therapy (2021)

A Systematic Review With Meta-Analysis of Efficacy of Cannabis and Cannabinoids for Inflammatory Bowel Disease: What Can We Learn From Randomized and Nonrandomized Studies? Journal of Clinical Gastroenterology (2021)

Kidney Disease, Injury

Endocannabinoid System and the Kidneys: From Renal Physiology to Injury and Disease Cannabis and Cannabinoid Research (2019)


Cannabis For Migraines  Dr. Ethan Russo (2019)

Clinical Endocannabinoid Deficiency Reconsidered: Current Research Supports the Theory in Migraine, Fibromyalgia, Irritable Bowel, and Other Treatment-Resistant Syndromes Dr. Ethan Russo (2016)

Clinical Endocannabinoid Deficiency (CECD): Can this Concept Explain Therapeutic Benefits of Cannabis in Migraine, Fibromyalgia, Irritable Bowel Syndrome and other Treatment-Resistant Conditions? Dr. Ethan Russo (2004)

Short and Long Term Effects of Cannabis on Headache and Migraine U.S. Association for the Study of Pain (2020)

Migraine Frequency Decrease Following Prolonged Medical Cannabis Treatment: A Cross-Sectional Study MDPI (2020)

Experience of migraine, its severity, and perceived efficacy of treatments among cannabis users Complementary Therapies in Medicine (2021)

Medical Cannabis, Headaches, and Migraines: A Review of the Current Literature Cureus (2021)

Medical Cannabis for Headache Pain: a Primer for Clinicians Current Pain and Headache Reports (2021)

Multiple Sclerosis (MS)

Therapeutic impact of orally administered cannabinoid oil extracts in an experimental autoimmune encephalomyelitis animal model of multiple sclerosis. Biochemical and Biophysical Research Communications (2019)

Safety and efficacy of low-dose medical cannabis oils in multiple sclerosis Multiple Sclerosis and Related Disorders (2021)

Patterns of Medical Cannabis Use Among Patients Diagnosed with Multiple Sclerosis Multiple Sclerosis and Related Disorders (2021)

Multiple Sclerosis, Cannabis Use, and Clinical Disability Cannabis and Cannabinoid Research (2018)

Cannabinoids and bladder symptoms in multiple sclerosis Multiple Sclerosis and Related Disorders (2021)


The Effectiveness of Common Cannabis Products for Treatment of Nausea Journal of Clinical Gastroenterology (2021)


Medical Cannabis in the Treatment of Neuropathy American Academy of Neurology (2021)


Role of Cannabinoids in Pain Management Dr. Ethan Russo and Andrea G Hohmann (2013)

Cannabis for Management of Pain: Assessment of Safety Study Dr. Mark Ware (2015)

The Role for Medical Cannabis in Chronic Pain Management Colloquium (2018)

Cannabis and Pain – A Clinical Review Cannabis and Cannabinoid Research (2017)

The Cannabinoids D8 THC, CBD, and HU-308 Act via Distinct Receptors to Reduce Corneal Pain and Inflammation Cannabis and Cannabinoid Research (2018)

Rheumatology – Chronic Pain CRAJ (2016)

Cannabis as an Adjunct to or Substitute for Opiates in the Treatment of Chronic Pain Journal of Psychoactive Drugs (2012)

Medical Marijuana for Treatment of Chronic Pain and Other Medical and Psychiatric Problems JAMA (2015)

Cannabinoids in Chronic Non-Cancer Pain Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders (2020)

Cannabis and Cannabinoids in the Treatment of Rheumatic Diseases Rambam Maimonides Medical Journal (2020)

Canadian clinical practice guidelines for the use of plant-based cannabis and cannabinoid-based products in the management of chronic non-cancer pain and co-occurring conditions: protocol for the systematic literature review BMJ (2020)

Medical Cannabis for the Management of Pain and Quality of Life in Chronic Pain Patients: A Prospective Observational Study Oxford Academic (2020)

Medical cannabis for the reduction of opioid dosage in the treatment of non-cancer chronic pain: a systematic review BMC (2020)

Medical Cannabis Treatment for Chronic Pain: Outcomes and Prediction of Response European Journal of Pain (2020)

Patient-reported outcomes in those consuming medical cannabis: a prospective longitudinal observational study in chronic pain patients Canadian Journal of Anesthesia (2021)

Medical cannabis treatment for chronic pain: Outcomes and prediction of response European Journal of Pain (2020)

No pain, all gain? Interim analyses from a longitudinal, observational study examining the impact of medical cannabis treatment on chronic pain and related symptoms American Psychological Association (2021)

Practical Strategies Using Medical Cannabis to Reduce Harms Associated With Long Term Opioid Use in Chronic Pain Dr. Caroline MacCallum (2021)

Consensus recommendations on dosing and administration of medical cannabis to treat chronic pain: results of a modified Delphi process Dr. Caroline MacCallum (2021)

Medical Cannabis for Chronic Noncancer Pain: A Systematic Review of Health Care Recommendations Hindawi Pain Research and Management (2021)

Consensus-based recommendations for titrating cannabinoids and tapering opioids for chronic pain control – Internation Journal of Clinical Practice (2021)

Use of Cannabis for Self-Management of Chronic Pelvic Pain Journal of Women’s Health (2021)

Prolonged Medical Cannabis Treatment is Associated With Quality of Life Improvement and Reduction of Analgesic Medication Consumption in Chronic Pain Patients Frontiers in Pharmacology (2021)

Cannabis-based medicines and medical cannabis for patients with neuropathic pain and other pain disorders: Nationwide register-based pharmacoepidemiologic comparison with propensity score matched controls European Journal of Pain (2021)

Palliative Care

Benefit of tetrahydrocannabinol versus cannabidiol for common palliative care symptoms Journal of Palliative Medicine (2019)

Short-Term Medical Cannabis Treatment Regimens Produced Beneficial Effects among Palliative Cancer Patients MDPI (2020)

Parkinson’s Disease

Cannabis For Parkinson’s And Alzheimer’s Diseases Dr. Ethan Russo (2019)

Effects of acute cannabidiol administration on anxiety and tremors induced by a Simulated Public Speaking Test in patients with Parkinson’s disease Journal of Psychopharmacology (2020)

Cannabis in Parkinson’s Disease: The Patient’s View Journal of Parkinson’s Disease (2021)


A novel control of human keratin expression: cannabinoid receptor 1-mediated signaling down-regulates the expression of keratins K6 and K16 in human keratinocytes in vitro and in situ Peer J (2013)

Pyoderma Gangrenosum

Topical Medical Cannabis: A New Treatment for Wound Pain Journal of Pain and Symptom Management (2017)


The Effect of Medical Cannabis on Pain Level and Quality of Sleep among Rheumatology Clinic Outpatients Hindawi (2021)


Targeting the cannabinoid pathway limits the development of fibrosis and autoimmunity in a mouse model of systemic sclerosis The American Journal of Pathology (2010)

Frequency and impact of symptoms experienced by patients with systemic sclerosis: results from a Canadian National Survey Rheumatology (2011)

The Effects of Cannabidiol, a Non-Intoxicating Compound of Cannabis, on the Cardiovascular System in Health and Disease International Journal of Molecular Sciences (2020)


Translating Endocannabinoid Biology into Clinical Practice: Cannabidiol for Stroke Prevention Cannabis and Cannabinoid Research (2017)


Treatment of Gilles de la Tourette Syndrome with cannabis-based medicine: results from a retrospective analysis and online survey Cannabis and Cannabinoid Research (2019)


Medical Cannabis Today (vol. 4, issue 1, 2019) Tilray (2019)

Insights Into Cannabis-Based Medicines  Proceedings From the Medical Cannabis Conference in Vienna (2018)

The Influence of DAT1, COMT, and BDNF Genetic Polymorphisms on Total and Subregional Hippocampal Volumes in Early Onset Heavy Cannabis Users Cannabis and Cannabinoid Research (2018)

Medical cannabis access, use, and substitution for prescription opioids and other substances: A survey of authorized medical cannabis patients International Journal of Drug Policy (2017)

2-Linoleoylglycerol Is a Partial Agonist of the Human Cannabinoid Type 1 Receptor That Can Suppress 2-Arachidonolyglycerol and Anandamide Activity Cannabis and Cannabinoid Research (2019)

Immune Responses Regulated by Cannabidiol Cannabis and Cannabinoid Research (2019)

Oral Cannabidiol Does Not Convert to D8 -THC or D9 -THC in Humans: A Pharmacokinetic Study in Healthy Subjects Cannabis and Cannabinoid Research (2019)

Tetrahydrocannabinolic acid is a potent PPRARγ agonist with neuroprotective activity British Journal of Pharmacology (2017)

Cannabidiol as an Intervention for Addictive Behaviors: A Systematic Review of the Evidence Libertas Academica (2015)

The effects of acute cannabidiol on cerebral blood flow and its relationship to memory: An arterial spin labelling magnetic resonance imaging study Journal of Psychopharmacology (2020)

Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects Dr. Ethan Russo (2011)

The relationship between cannabis use and patient outcomes in the medication-based treatment of opioid use disorder: A systematic review Clinical Psychology Review (2020)

Effects of Cannabidiol on the Long-Term Toxicity and Lifespan in the Preclinical Model Caenorhabditis elegans  Cannabis and Cannabinoid Research (2020)

Effect of Cannabidiol and Tetrahydrocannabinol on Driving Performance JAMA (2020)

Cannabis use is associated with reduced risk of exposure to fentanyl among people on opioid against therapy during community-wide overdose crisis Drug and Alcohol Dependence (2020)

Effects of cannabis use on alcohol consumption in a sample of treatment-engaged heavy drinkers in Colorado Society for the Study of Addiction (2021)

Opioid Prescribing in Canada following the Legalization of Cannabis: A Clinical and Economic Time-Series Analysis Applied Health Economics and Health Policy (2021)

Reductions in alcohol use following medical cannabis initiation: results from a large cross-sectional survey of medical cannabis patients in Canada International Journal of Drug Policy (2020)

Duration of Neurocognitive Impairment With Medical Cannabis Use: A Scoping Review Frontiers in Pharmacology (2021)

Effect of cannabis on oxaliplatin-induced peripheral neuropathy among oncology patients: a retrospective analysis Therapeutic Advances in Medical Oncology (2021)

Topical Cannabis-Based Medicines –  A Novel Adjuvant Treatment for Venous Leg Ulcers: An Open-Label Trial Experimental Dermatology (2021)

“Is medical cannabis safe for my patients?” A practical review of cannabis safety considerations Dr. Caroline MacCallum (2021)

Duration of Neurocognitive Impairment With Medical Cannabis Use: A Scoping Review Frontiers in Psychiatry (2021)